US › Healthcare

Electromed Inc (ELMD)

US · Healthcare · Medical Devices

$26.35+0.76%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$19.4M

Revenue YoY

+11.6%

Net profit

$3.4M

Profit YoY

+54.3%

EPS

$0.39

EPS estimate

$0.32

Net margin

17.5%

EPS came in at 0.39 against a street estimate of 0.32 — a beat of 21.9%.

Key statistics

Market cap

$228.0M

P/E

21.0

Forward P/E

20.2

P/B

4.13

Book value

$6.45

EPS (TTM)

$1.30

52-week high

$47.40

52-week low

$23.01

50-day MA

$38.94

200-day MA

$31.44

Beta

0.46

Analyst view

Analysts rate Electromed Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $48.50.

Shareholding

Insiders

17.01%

Institutions

60.47%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Electromed Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.